CLEARSIDE BIOMEDICAL INC (CLSD) Stock Balance Sheet
NASDAQ:CLSD - Nasdaq - US1850631045 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 13.63M | 20.02M | 28.92M | 48.26M | 30.44M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 1.54M | 507.00K | 170.00K | 0.00 | 10.00M | |||
| Other Current Assets | 798.00K | 747.00K | 1.03M | 1.14M | 1.70M | |||
| Total Current Assets | 15.96M | 21.27M | 30.12M | 49.40M | 42.14M | |||
| Non-Current Assets | ||||||||
| PPE Net | 3.67M | 3.82M | 3.87M | 1.87M | 610.00K | |||
| Other Non-Current Assets | 30.00K | 30.00K | 30.00K | 30.00K | 160.00K | |||
| Total Non-Current Assets | 3.70M | 3.85M | 3.90M | 1.90M | 760.00K | |||
| TOTAL ASSETS | 19.67M | 25.13M | 34.02M | 51.30M | 42.90M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | 0.00 | |||
| Accrued Expenses | 2.38M | 3.34M | 4.53M | 4.53M | 3.70M | |||
| Accounts Payable | 1.91M | 1.45M | 2.21M | 1.05M | 940.00K | |||
| Other Current Liabilities | 715.00K | 0.00 | 75.00K | 210.00K | 0.00 | |||
| Total Current Liabilities | 5.01M | 4.79M | 6.81M | 5.78M | 4.64M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 60.57M | 59.19M | 43.12M | 34.91M | 290.00K | |||
| Total Non-Current Liabilities | 60.57M | 59.19M | 43.12M | 34.92M | 290.00K | |||
| TOTAL LIABILITIES | 65.58M | 63.98M | 49.93M | 40.70M | 4.93M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -363.50M | -355.27M | -320.92M | -288.44M | -255.49M | |||
| Additional Paid In Capital | 317.51M | 316.34M | 304.95M | 298.98M | 293.41M | |||
| Common Shares | 77.00K | 77.00K | 63.00K | 60.00K | 60.00K | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 77.27M | 76.58M | 62.85M | 60.64M | 59.72M | |||
| Tangible Book Value per Share | -0.59 | -0.51 | -0.25 | 0.17 | 0.64 | |||
| Total Shareholders' Equity | -45.91M | -38.85M | -15.91M | 10.61M | 37.98M | |||
| TOTAL LIABILITIES AND EQUITY | 19.67M | 25.13M | 34.02M | 51.30M | 42.90M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 3.19 | 4.44 | 4.42 | 8.55 | 9.08 | |||
| Return On Assets (ROA) | -156.66% | -136.72% | -95.49% | -64.23% | 0.89% | |||
| Return On Equity (ROE) | N/A | N/A | N/A | -310.56% | 1.00% | |||
All data in USD , ROIC based on taxRate of 0.21